A Novel Metabolic Reprogramming Strategy for the Treatment of Diabetes‐Associated Breast Cancer

A Novel Metabolic Reprogramming Strategy for the Treatment of Diabetes‐Associated Breast Cancer

Abstract Diabetes is directly related to the risk of breast cancer (BC) occurrence and worsened BC prognosis. Currently, there are no specific treatments for diabetes‐associated BC. This paper aims to understand the fundamental mechanisms of diabetes‐induced BC progression and to develop personalize...

Full description

Bibliographic Details
Main Authors: Qiongyu Hao, Zhimin Huang, Qun Li, Dingxie Liu, Piwen Wang, Kun Wang, Jieqing Li, Wei Cao, Wenhong Deng, Ke Wu, Rui Su, Zhongmin Liu, Jay Vadgama, Yong Wu
Format: Article
Language:English
Published: Wiley 2022-02-01
Series:Advanced Science
Subjects:
breast cancer
diabetes
lactate
MCT4
metabolic reprogramming
metformin
Online Access:https://doi.org/10.1002/advs.202102303

Internet

https://doi.org/10.1002/advs.202102303

Similar Items